Abstract
Most of our current knowledge of melanoma is derived from the study of patients from populations of European descent, for whom public health, sun protection initiatives and screening measures have appreciably decreased disease mortality. Notably, some melanoma subtypes that most commonly develop in other populations are not associated with exposure to ultraviolet (UV) light, suggesting a different disease aetiology. Further study of these subtypes is necessary to understand their risk factors and genomic architecture, and to tailor therapies and public health campaigns to benefit patients of all ethnic groups.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019
Archives of Dermatological Research Open Access 29 September 2023
-
High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types
BMC Cancer Open Access 29 October 2021
-
Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study
BMC Cancer Open Access 16 April 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lozano, R. et al. Lancet 380, 2095–2128 (2012).
International Agency for Research on Cancer. World Cancer Report 2014 (eds Stewart, B. W. & Wild, C. P.) (IARC Publications, 2014).
Erdmann, F. et al. Int. J. Cancer 132, 385–400 (2013).
Lino-Silva, L. S. et al. Ann. Surg. Oncol. 23, 4189–4194 (2016).
Zell, J. A. et al. J. Clin. Oncol. 26, 66–75 (2008).
Demierre, M.-F., Chung, C., Miller, D. R. & Geller, A. C. Arch. Dermatol. 141, 745–750 (2005).
Alexandrov, L. B. et al. Nature 500, 415–421 (2013).
Cancer Genome Atlas Network. Cell 161, 1681–1696 (2015).
Aoude, L. G., Wadt, K. A. W., Pritchard, A. L. & Hayward, N. K. Pigment Cell Melanoma Res. 28, 148–160 (2015).
Law, M. H. et al. Nat. Genet. 47, 987–995 (2015).
Merkel, E. A. & Gerami, P. Lab. Invest. http://dx.doi.org/10.1038/labinvest.2016.147 (2017).
Greaves, W. O. et al. J. Mol. Diagn. 15, 220–226 (2012).
Hodi, F. S. et al. J. Clin. Oncol. 31, 3182–3190 (2013).
Shoushtari, A. N. et al. Cancer 122, 3354–3362 (2016).
Colby, S. L. & Ortman, J. M. US Census Bureau https://www.census.gov/content/dam/Census/library/publications/2015/demo/p25-1143.pdf (2015).
Acknowledgements
The authors thank R. van Doorn, V. V. Iyer and M. del C. Ávila-Arcos for helpful comments.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information S1 (figure)
Distribution of common melanoma subtypes across different countries (PDF 715 kb)
Rights and permissions
About this article
Cite this article
Ossio, R., Roldán-Marín, R., Martínez-Said, H. et al. Melanoma: a global perspective. Nat Rev Cancer 17, 393–394 (2017). https://doi.org/10.1038/nrc.2017.43
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc.2017.43
This article is cited by
-
Obstacles and opportunities in studying melanoma in Latin America
Nature Cancer (2023)
-
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019
Archives of Dermatological Research (2023)
-
In vitro evaluation of p-coumaric acid and naringin combination in human epidermoid carcinoma cell line (A431)
Medical Oncology (2023)
-
Revisiting the melanomagenic pathways and current therapeutic approaches
Molecular Biology Reports (2022)
-
High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types
BMC Cancer (2021)